You are here

Sapacitabine

After nearly 20 years, Cyclacel kicks phase 3 leukemia drug back to Daiichi

Fierce Biotech

Thu, 11/10/22 - 10:39 am

Will Cyclacel Pharmaceuticals’ Pipeline Be a Success?

Wall St. Cheat Sheet

Wed, 12/5/12 - 10:23 am

Cyclacel Heats Up On Clinical Trial Progression

Seeking Alpha

Wed, 10/17/12 - 11:56 am

myelodysplastic syndrome

Cyclacel: An Intriguing Long Shot

Seeking Alpha

Tue, 03/20/12 - 10:35 am

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) Remains as Far from FDA Approval as Ever Despite Recommendation from DSMB

OTC Equity

Sat, 10/15/11 - 01:11 pm

acute myeloid leukemia

Cyclacel rallies on drug update

Marketwatch

Fri, 12/3/10 - 11:04 am

Cyclacel Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 ASH Annual Meeting

Yahoo/GlobeNewsWire

Sat, 12/5/09 - 12:18 pm

acute myeloid leukemia

myelodysplastic syndrome